Although AOM liraglutide (Saxenda) has been approved for treatment of obesity in adolescents since late 2020 ( 5 ), the approval of AOM semaglutide (Wegovy) in December 2022 for treatment of obesity for adolescents prompted new excitement ( 6 )
(verified owner) Verified review - view original Have only been on this medication a short while but it seems to be doing what I was expecting it to and that is amazing
-Take it with a full glass of water
Regular blood sugar monitoring, such as through regular A1C tests or checking fingerstick glucose levels at home, can alert the patient if their sugar levels have not sufficiently decreased
Many herbal products intended for oral use are marketed as dietary supplements
He highlighted three key advantages of semaglutide in diabetes care: reduced risk of hypoglycemia or low blood sugar levels compared to traditional therapies, strong HbA1c reduction, and benefits related to weight and organ protection